Perjeta, formally called pertuzumab, signifies a important advancement in treating HER2-positive breast cancer. The medication works by blocking a particular pathway that helps cancer cells proliferate. Unlike some other HER2-targeted therapies, pertuzumab doesn’t directly block the HER2 receptor… Read More